Clinical trial
pReOperative Dostarlimab and Novel Therapies in EndOmetrial Cancer
NCT07115927 is registered in ClinicalTrials.gov with University College, London as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- pReOperative Dostarlimab and Novel Therapies in EndOmetrial Cancer
- Lead sponsor
- University College, London
- Phase
- Phase 2
- Overall status
- Not yet recruiting
- Start date
- September 30, 2025
- Completion date
- January 31, 2031
- Enrollment
- 40 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
endometrial cancer